Cargando…

Predicting the emergence of drug-resistant HSV-2: new predictions

BACKGROUND: Mathematical models can be used to predict the emergence and transmission of antiviral resistance. Previously it has been predicted that high usage of antivirals (in immunocompetent populations) to treat Herpes Simplex Virus type 2 (HSV-2) would only lead to fairly low levels of antivira...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gershengorn, Hayley B, Darby, Graham, Blower, Sally M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154092/ https://www.ncbi.nlm.nih.gov/pubmed/12659657 http://dx.doi.org/10.1186/1471-2334-3-1

Ejemplares similares

The Emergence of HIV Transmitted Resistance in Botswana: “When Will the WHO Detection Threshold Be Exceeded?”
por: Vardavas, Raffaele, et al.
Publicado: (2007)

Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA
por: Morrow, Rhoda Ashley, et al.
Publicado: (2005)

Universal Access to HIV Treatment versus Universal ‘Test and Treat’: Transmission, Drug Resistance & Treatment Costs
por: Wagner, Bradley G., et al.
Publicado: (2012)

Predicting the potential for within-flight transmission and global dissemination of MERS
por: Coburn, Brian J, et al.
Publicado: (2014)

A Replication-Defective Herpes Simplex Virus (HSV)-2 Vaccine, HSV529, is Safe and Well-Tolerated in Adults with or without HSV Infection and Induces Significant HSV-2-Specific Antibody Responses in HSV Seronegative Individuals
por: Dropulic, Lesia, et al.
Publicado: (2017)

Correction: Use of "biokitHSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA
por: Morrow, Rhoda Ashley, et al.
Publicado: (2007)

Worldwide circulation of HSV-2 × HSV-1 recombinant strains
por: Koelle, David M., et al.
Publicado: (2017)

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
por: Gilbert, Peter B., et al.
Publicado: (2017)

Predicting the transmission of SARS-CoV-2 in Africa: the case of Namibia
por: Okano, Justin T, et al.
Publicado: (2022)

Sometimes It Is Okay to Get Personal: Individualizing Targets in Critical Care
por: Gershengorn, Hayley B.
Publicado: (2020)

Early adoption of critical care interventions is unjustifiable without concomitant effectiveness study
por: Gershengorn, Hayley B.
Publicado: (2020)

Hyperoxemia – too much of a good thing?
por: Gershengorn, Hayley
Publicado: (2014)

A Systematic Review of Second-Line Treatments in Antiviral Resistant Strains of HSV-1, HSV-2, and VZV
por: Lince, Kimberly C, et al.
Publicado: (2023)

Negative epidemiological association between HSV-1 and HSV-2 infections
por: Nasrallah, Gheyath K., et al.
Publicado: (2019)

HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles
por: LeGoff, Jérôme, et al.
Publicado: (2007)

Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks
por: Wagner, Bradley G., et al.
Publicado: (2012)

A case of an atypical resistant granulomatous HSV-1 and HSV-2 ulceration in an AIDS patient treated with intralesional cidofovir
por: Saling, Christopher, et al.
Publicado: (2019)

Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance
por: Supervie, Virginie, et al.
Publicado: (2011)

Molecular docking analysis of a secondary metabolite with the glycoprotein receptors of HSV 1 and HSV 2
por: Saran, Natarajan, et al.
Publicado: (2019)

Getting What You Pay For
por: Lee, Jessica T., et al.
Publicado: (2022)

Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial
por: Chandra, Janin, et al.
Publicado: (2019)

Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons
por: Mujugira, Andrew, et al.
Publicado: (2011)

Linking prediction models to government ordinances to support hospital operations during the COVID-19 pandemic
por: Warde, Prem Rajendra, et al.
Publicado: (2021)

LAT Region Factors Mediating Differential Neuronal Tropism of HSV-1 and HSV-2 Do Not Act in Trans
por: Bertke, Andrea S., et al.
Publicado: (2012)

Dysregulation of Autophagy in Murine Fibroblasts Resistant to HSV-1 Infection
por: Le Sage, Valerie, et al.
Publicado: (2012)

Corrigendum: Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance
por: Supervie, Virginie, et al.
Publicado: (2015)

Functional prediction of differentially expressed lncRNAs in HSV-1 infected human foreskin fibroblasts
por: Hu, Benxia, et al.
Publicado: (2016)

Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV
por: Houston, David M. J., et al.
Publicado: (2017)

Hospital Capacity Strain as a Window into the Value of ICU Admission: Some Answers, More Questions
por: Barbash, Ian J., et al.
Publicado: (2021)

A Macaque Model to Study Vaginal HSV-2/Immunodeficiency Virus Co-Infection and the Impact of HSV-2 on Microbicide Efficacy
por: Crostarosa, Federica, et al.
Publicado: (2009)

Predictive Value of Sequential Organ Failure Assessment Score across Patients with and without COVID-19 Infection
por: Gershengorn, Hayley B., et al.
Publicado: (2022)

Stress Hormones Epinephrine and Corticosterone Selectively Reactivate HSV-1 and HSV-2 in Sympathetic and Sensory Neurons
por: Goswami, Poorna, et al.
Publicado: (2022)

Autophagy as a Mechanism for Adaptive Prediction-Mediated Emergence of Drug Resistance
por: Nivedita, Nivedita, et al.
Publicado: (2021)

Simultaneous detection of HSV-1, HSV-2 and VZV in clinical samples by multiplex polymerase chain reaction (MPCR)
por: Sharifzad, F., et al.
Publicado: (2006)

Effect of Copper Acyclovir Complexes on Herpes Simplex Virus Type 1 and Type 2 (HSV-1, HSV-2) Infection in Cultured Cells
por: Panteva, M., et al.
Publicado: (1998)

Immunogenicity, Protective Efficacy, and Non-Replicative Status of the HSV-2 Vaccine Candidate HSV529 in Mice and Guinea Pigs
por: Bernard, Marie-Clotilde, et al.
Publicado: (2015)

Evaluation of RealStar® Alpha Herpesvirus PCR Kit for Detection of HSV-1, HSV-2, and VZV in Clinical Specimens
por: Yip, Cyril C. Y., et al.
Publicado: (2019)

Assessing delivery of mechanical ventilation: risks and benefits of large databases
por: Hua, May, et al.
Publicado: (2020)

HSV-2 Co-Infection as a Driver of HIV Transmission among Heterosexual Non-Injecting Drug Users in New York City
por: Des Jarlais, Don C., et al.
Publicado: (2014)

Comparative Evaluation of AmpliVue HSV 1+2 Assay with ELVIS Culture for Detecting Herpes Simplex Virus 1 (HSV-1) and HSV-2 in Clinical Specimens
por: Granato, Paul A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7u9f61pdpu3qeb40sjeocivh8h